The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
Bayesian optimal interval based on both efficacy and toxicity outcomes (BOIN-ET) design is a model-assisted oncology phase I/II trial design, aiming to establish an optimal biological dose accounting for efficacy and toxicity in the framework of dose-finding. Some extensions of BOIN-ET design are also available to allow for time-to-event efficacy and toxicity outcomes based on cumulative and pending data (time-to-event BOIN-ET: TITE-BOIN-ET), ordinal graded efficacy and toxicity outcomes (generalized BOIN-ET: gBOIN-ET), and their combination (TITE-gBOIN-ET). 'boinet' is a package to implement the BOIN-ET design family and supports the conduct of simulation studies to assess operating characteristics of BOIN-ET, TITE-BOIN-ET, gBOIN-ET, and TITE-gBOIN-ET, where users can choose design parameters in flexible and straightforward ways depending on their own application.
Version: | 1.1.0 |
Imports: | Iso, mfp, copula |
Suggests: | testthat (≥ 3.0.0) |
Published: | 2024-08-24 |
DOI: | 10.32614/CRAN.package.boinet |
Author: | Yusuke Yamaguchi [aut, cre], Kentaro Takeda [aut] |
Maintainer: | Yusuke Yamaguchi <yamagubed at gmail.com> |
License: | MIT + file LICENSE |
NeedsCompilation: | no |
Materials: | README NEWS |
CRAN checks: | boinet results |
Reference manual: | boinet.pdf |
Package source: | boinet_1.1.0.tar.gz |
Windows binaries: | r-devel: boinet_1.1.0.zip, r-release: boinet_1.1.0.zip, r-oldrel: boinet_1.1.0.zip |
macOS binaries: | r-release (arm64): boinet_1.1.0.tgz, r-oldrel (arm64): boinet_1.1.0.tgz, r-release (x86_64): boinet_1.1.0.tgz, r-oldrel (x86_64): boinet_1.1.0.tgz |
Old sources: | boinet archive |
Please use the canonical form https://CRAN.R-project.org/package=boinet to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.